283 related articles for article (PubMed ID: 22713753)
1. SUMO1 modification of PTEN regulates tumorigenesis by controlling its association with the plasma membrane.
Huang J; Yan J; Zhang J; Zhu S; Wang Y; Shi T; Zhu C; Chen C; Liu X; Cheng J; Mustelin T; Feng GS; Chen G; Yu J
Nat Commun; 2012 Jun; 3():911. PubMed ID: 22713753
[TBL] [Abstract][Full Text] [Related]
2. PIASxα ligase enhances SUMO1 modification of PTEN protein as a SUMO E3 ligase.
Wang W; Chen Y; Wang S; Hu N; Cao Z; Wang W; Tong T; Zhang X
J Biol Chem; 2014 Feb; 289(6):3217-30. PubMed ID: 24344134
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the tumor suppressor PTEN by SUMO.
González-Santamaría J; Campagna M; Ortega-Molina A; Marcos-Villar L; de la Cruz-Herrera CF; González D; Gallego P; Lopitz-Otsoa F; Esteban M; Rodríguez MS; Serrano M; Rivas C
Cell Death Dis; 2012 Sep; 3(9):e393. PubMed ID: 23013792
[TBL] [Abstract][Full Text] [Related]
4. PTEN inhibits BMI1 function independently of its phosphatase activity.
Fan C; He L; Kapoor A; Rybak AP; De Melo J; Cutz JC; Tang D
Mol Cancer; 2009 Nov; 8():98. PubMed ID: 19903340
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium.
Nguyen HN; Afkari Y; Senoo H; Sesaki H; Devreotes PN; Iijima M
Oncogene; 2014 Dec; 33(50):5688-96. PubMed ID: 24292679
[TBL] [Abstract][Full Text] [Related]
6. SUMO modification of Akt regulates global SUMOylation and substrate SUMOylation specificity through Akt phosphorylation of Ubc9 and SUMO1.
Lin CH; Liu SY; Lee EH
Oncogene; 2016 Feb; 35(5):595-607. PubMed ID: 25867063
[TBL] [Abstract][Full Text] [Related]
7. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN.
Rahdar M; Inoue T; Meyer T; Zhang J; Vazquez F; Devreotes PN
Proc Natl Acad Sci U S A; 2009 Jan; 106(2):480-5. PubMed ID: 19114656
[TBL] [Abstract][Full Text] [Related]
8. Membrane-binding and activation mechanism of PTEN.
Das S; Dixon JE; Cho W
Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7491-6. PubMed ID: 12808147
[TBL] [Abstract][Full Text] [Related]
9. Interactions of phosphatase and tensin homologue (PTEN) proteins with phosphatidylinositol phosphates: insights from molecular dynamics simulations of PTEN and voltage sensitive phosphatase.
Kalli AC; Devaney I; Sansom MS
Biochemistry; 2014 Mar; 53(11):1724-32. PubMed ID: 24588644
[TBL] [Abstract][Full Text] [Related]
10. PTEN, more than the AKT pathway.
Blanco-Aparicio C; Renner O; Leal JF; Carnero A
Carcinogenesis; 2007 Jul; 28(7):1379-86. PubMed ID: 17341655
[TBL] [Abstract][Full Text] [Related]
11. Expression of Human PTEN-L in a Yeast Heterologous Model Unveils Specific N-Terminal Motifs Controlling PTEN-L Subcellular Localization and Function.
Fernández-Acero T; Bertalmio E; Luna S; Mingo J; Bravo-Plaza I; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
Cells; 2019 Nov; 8(12):. PubMed ID: 31779149
[TBL] [Abstract][Full Text] [Related]
12. Defining the membrane-associated state of the PTEN tumor suppressor protein.
Lumb CN; Sansom MS
Biophys J; 2013 Feb; 104(3):613-21. PubMed ID: 23442912
[TBL] [Abstract][Full Text] [Related]
13. A new class of cancer-associated PTEN mutations defined by membrane translocation defects.
Nguyen HN; Yang JM; Rahdar M; Keniry M; Swaney KF; Parsons R; Park BH; Sesaki H; Devreotes PN; Iijima M
Oncogene; 2015 Jul; 34(28):3737-43. PubMed ID: 25263454
[TBL] [Abstract][Full Text] [Related]
14. A short N-terminal sequence of PTEN controls cytoplasmic localization and is required for suppression of cell growth.
Denning G; Jean-Joseph B; Prince C; Durden DL; Vogt PK
Oncogene; 2007 Jun; 26(27):3930-40. PubMed ID: 17213812
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational regulation of membrane type 1-matrix metalloproteinase (MT1-MMP) in mouse PTEN null prostate cancer cells: Enhanced surface expression and differential O-glycosylation of MT1-MMP.
Kim S; Huang W; Mottillo EP; Sohail A; Ham YA; Conley-Lacomb MK; Kim CJ; Tzivion G; Kim HR; Wang S; Chen YQ; Fridman R
Biochim Biophys Acta; 2010 Nov; 1803(11):1287-97. PubMed ID: 20620173
[TBL] [Abstract][Full Text] [Related]
16. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
17. PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system.
Jagan IC; Deevi RK; Fatehullah A; Topley R; Eves J; Stevenson M; Loughrey M; Arthur K; Campbell FC
Neoplasia; 2013 Nov; 15(11):1218-30. PubMed ID: 24348097
[TBL] [Abstract][Full Text] [Related]
18. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction.
Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z
Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130
[TBL] [Abstract][Full Text] [Related]
19. Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells.
He L; Ingram A; Rybak AP; Tang D
J Clin Invest; 2010 Jun; 120(6):2094-108. PubMed ID: 20458142
[TBL] [Abstract][Full Text] [Related]
20. PTEN lipid phosphatase inactivation links the hippo and PI3K/Akt pathways to induce gastric tumorigenesis.
Xu W; Yang Z; Xie C; Zhu Y; Shu X; Zhang Z; Li N; Chai N; Zhang S; Wu K; Nie Y; Lu N
J Exp Clin Cancer Res; 2018 Aug; 37(1):198. PubMed ID: 30134988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
